olivlawolivlaw

olivLaw · European equity research

Target Healthcare REIT plc THRL.L

United Kingdom · London Stock Exchange · Vertical: Listed companies from United Kingdom

1.20GBP−0.66% · 1 dayClose 06 Nov 2026

Target Healthcare REIT plc owns a portfolio of UK care homes leased to operators on long-term contracts. In fiscal 2025 rent cover stayed above 1.9x and occupancy stood at 86%, leaving room for growth, a relevant point given pressures in the social care sector.

At the close of 06 Nov 2026, Target Healthcare REIT plc (THRL.L) stock was 1.20 GBP (−0.66% on the day), with market capitalisation 744.3 m GBP, P/E 12.2 on diluted EPS of 0.10 GBP over the last 12 months, dividend yield 4.87%, beta 0.39, 52-week range 0.93–1.21 GBP.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
744.3 m GBP
shares as of 30 Jun 2025
P/E (TTM)
12.2
Diluted EPS TTM 0.10 · TTM to 30 Jun 2025
E/P (TTM)
8.18%
TTM to 30 Jun 2025
Dividend yield
4.87%
DPS 12m 0.06
Beta (2y)
0.39
Volatility (1y) 18%
52-week range
0.931.21

Price history

Loading chart…

Technical reading

RSI (14)
67.8
strong (55–70)
Bollinger (20, 2)
1.12 – 1.21
in the upper half of the band · %B 0.86 · band width 8.5%
SMA 50 / 200
1.14 / 1.09
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
0.02 / 0.02
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month+6.2%−0.2%+6.4 pp—
3 months+6.4%−5.4%+11.8 pp—
6 months+11.5%+4.4%+7.1 pp—
Year to date+23.0%+6.5%+16.5 pp—
1 year+26.6%+10.0%+16.6 pp+3.7%
3 years+51.7%+48.6%+3.1 pp+24.5%
5 years+0.2%+41.4%−41.3 pp—
Max drawdown (1y)
−8.9%
17 Feb 2026 → 27 Mar 2026
Max drawdown (5y)
−45.2%
19 Nov 2021 → 21 Aug 2023
Compound annual growth (5y)
+0.0%
EURO STOXX 50 +7.2%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 100 percentile of its own 2-quarter history (min 6.7, median 8.6, max 10.6; quarters with earnings only).

Fiscal years

Fiscal year202320242025
Revenue67.7 m69.6 m72.9 m
Revenue YoYunavailable+2.7%+4.9%
Net income-6.6 m73.0 m60.8 m
Net income YoYunavailableunavailable−16.7%
Diluted EPS-0.010.120.10
Diluted EPS YoYunavailableunavailable−16.7%
net %-9.7%105.0%83.4%
Free cash flowunavailableunavailableunavailable

Balance sheet & financial health

Fiscal year 2025 · 30 Jun 2025

Cash
39.6 m GBP
Financial debt
240.3 m GBP
Net debt
200.7 m GBP
Equity
712.5 m GBP
Total assets
986.2 m GBP
Debt / equity
0.34x
Current ratio
0.39x
ROE
8.7%
ROA
6.2%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (GBP)

Margins

Income statement · GBP

Revenue
2023
67.7 m
2024
69.6 m
2025
72.9 m

esef· 18 Nov 2025verified

Interest expense
2023
10.3 m
2024
11.7 m
2025
11.5 m

esef· 18 Nov 2025verified

Pre-tax income
2023
-6.6 m
2024
73.0 m
2025
60.8 m

esef· 18 Nov 2025verified

Income tax
2023
0
2024
0
2025
0

esef· 18 Nov 2025verified

Net income
2023
-6.6 m
2024
73.0 m
2025
60.8 m

esef· 18 Nov 2025verified

Diluted EPS
2023
-0.01
2024
0.12
2025
0.10

esef· 18 Nov 2025verified

Dividend per share
2023
0.06
2024
0.06
2025
0.06

esef· 18 Nov 2025verified

Balance sheet · GBP

Cash
2023
15.4 m
2024
38.9 m
2025
39.6 m

esef· 18 Nov 2025verified

Receivables
2023
9.5 m
2024
5.7 m
2025
3.7 m

esef· 18 Nov 2025verified

Current assets
2023
24.8 m
2024
44.6 m
2025
43.9 m

esef· 18 Nov 2025verified

Total assets
2023
908.3 m
2024
967.4 m
2025
986.2 m

esef· 18 Nov 2025verified

Accounts payable
2023
18.3 m
2024
27.5 m
2025
20.7 m

esef· 18 Nov 2025verified

Short-term debt
2023
—
2024
0
2025
91.9 m

esef· 18 Nov 2025verified

Long-term debt
2023
227.1 m
2024
240.7 m
2025
148.4 m

esef· 18 Nov 2025verified

Current liabilities
2023
—
2024
27.5 m
2025
112.6 m

esef· 18 Nov 2025verified

Total liabilities
2023
253.5 m
2024
278.1 m
2025
273.7 m

esef· 18 Nov 2025verified

Equity
2023
654.8 m
2024
689.3 m
2025
712.5 m

esef· 18 Nov 2025verified

Shares outstanding at year end
2023
620.0 m
2024
620.4 m
2025
620.2 m

esef· 18 Nov 2025derived

Cash flow · GBP

Operating cash flow
2023
29.7 m
2024
42.3 m
2025
41.1 m

esef· 18 Nov 2025verified

Investing cash flow
2023
-3.6 m
2024
3.4 m
2025
-3.2 m

esef· 18 Nov 2025verified

Financing cash flow
2023
-45.2 m
2024
-22.2 m
2025
-37.1 m

esef· 18 Nov 2025verified

Dividends paid
2023
40.3 m
2024
35.2 m
2025
36.1 m

esef· 18 Nov 2025verified

Computed indicators

Growth

Revenue growth (YoY)
4.9%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
-16.7%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-16.7%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
unavailable
input data missing

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
83.4%
computed by olivLawFY 2025
FCF margin
unavailable
input data missing

Returns

ROE
8.7%
computed by olivLawFY 2025 · balance sheet at 30 Jun 2025
ROA
6.2%
computed by olivLawFY 2025 · balance sheet at 30 Jun 2025
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
59.5%
computed by olivLawFY 2025
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
200.7 m GBP
computed by olivLawbalance sheet at 30 Jun 2025
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.3x
computed by olivLawbalance sheet at 30 Jun 2025
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
0.4x
computed by olivLawbalance sheet at 30 Jun 2025
Quick ratio
unavailable
input data missing
Cash ratio
0.4x
computed by olivLawbalance sheet at 30 Jun 2025

Cash

Operating cash flow
41.1 m GBP
computed by olivLawFY 2025
Capital expenditure
unavailable
input data missing
Free cash flow
unavailable
input data missing
FCF conversion
unavailable
input data missing
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
23 days
computed by olivLawFY 2025 · balance sheet at 30 Jun 2025
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
744.3 m GBP
computed by olivLawbalance sheet at 30 Jun 2025
Enterprise value
944.9 m GBP
computed by olivLawbalance sheet at 30 Jun 2025
Market cap / net income TTM
12.2x
computed by olivLawFY 2025
P/E (TTM)
12.2x
computed by olivLawFY 2025
Earnings yield
8.2%
computed by olivLawFY 2025
P/B
1.0x
computed by olivLawbalance sheet at 30 Jun 2025
P/S
10.2x
computed by olivLawFY 2025 · balance sheet at 30 Jun 2025
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
13.0x
computed by olivLawFY 2025 · balance sheet at 30 Jun 2025
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
4.9%
computed by olivLawFY 2025
Shareholder yield (distributions)
4.9%
computed by olivLawFY 2025 · balance sheet at 30 Jun 2025

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 4 of at least 6
  • score weight coverage: 27.1% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

1.20 GBP

06 Nov 2026Source: olivLaw, closing series

Market cap: 744.3 m GBP

Key indicators

Market capitalisation
744.3 m GBP
computed by olivLawbalance sheet at 30 Jun 2025
P/E (TTM)
12.2x
computed by olivLawFY 2025
P/B
1.0x
computed by olivLawbalance sheet at 30 Jun 2025
EV/EBITDA
unavailable
input data missing
ROE
8.7%
computed by olivLawFY 2025 · balance sheet at 30 Jun 2025
Net margin
83.4%
computed by olivLawFY 2025
Revenue growth (YoY)
4.9%
computed by olivLawFY 2025
Dividend yield
4.9%
computed by olivLawFY 2025

Coverage and freshness

22/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Jun 2025
Latest balance sheet date: 30 Jun 2025
Share count (cover of the latest filing), as of: 30 Jun 2025
Source: esefpublished 18 Nov 2025
verified 72derived 3

The data is older than the freshness threshold.

Score by group

27% · Insufficient data

Estimated value range

unavailable — no valuation assumptions for the reporting currency

Valuation assumptions are editorial choices, not measured; beta is not measured.

Valuation methods

    Assumptions (illustrative, editorial)

    Risk-free rate
    6.5%
    Equity risk premium
    6.0%
    Beta (default)
    1.00
    Cost of equity
    12.5%
    Terminal growth
    3.0%

    Factor scorecard

    Insufficient data

    Minimum-evidence gate: indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%

    FactorValueScoreWeight used
    ROIC · Qualityunavailableunavailable—
    Net margin · Quality83.4%100 (vs peers)23%
    FCF conversion · Qualityunavailableunavailable—
    Revenue CAGR 3Y · Growthunavailableunavailable—
    EPS CAGR 3Y · Growthunavailableunavailable—
    Net debt / EBITDA · Balance sheetunavailableunavailable—
    Interest coverage · Balance sheetunavailableunavailable—
    Current ratio · Balance sheet0.4x0 (on a fixed band)15%
    P/E (TTM) · Valuation12.2x72 (vs peers)38%
    EV/EBITDA · Valuationunavailableunavailable—
    FCF yield · Valuationunavailableunavailable—
    Shareholder yield (distributions) · Returns4.9%69 (on a fixed band)23%
    Payout ratio (FCF) · Returnsunavailableunavailable—

    Factors without a value were dropped; the remaining weights were renormalised.

    Score groups

    • Balance sheet· partial0/100 · 1/3 factors with a value
    • Growth· partialunavailable · 0/2 factors with a value
    • Quality· partial100/100 · 1/3 factors with a value
    • Returns· partial69/100 · 1/2 factors with a value
    • Valuation· partial72/100 · 1/3 factors with a value

    A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

    Memo

    TARGET HEALTHCARE REIT PLC (THRL.L). Latest full fiscal year: 2025; data up to 2025-06-30.

    Figures computed from the financial statements: revenue 72.9 m GBP in 2025; YoY growth 4.9%; net margin 83.4%; ROE 8.7%.

    The estimated value range is 0.83–1.20 GBP per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 1.01 GBP, the price of 1.20 GBP leaves a potential of -15.6% (value / price − 1) and a margin of safety of -18.5% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

    Insufficient data for a verdict (indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%).

    Text generated deterministically from the figures shown; no language model. Not investment advice.

    What supports the thesis

    • Net margin: 83.4%
    • P/E (TTM): 12.2x

    What contradicts it

    • Current ratio: 0.4x
    • The price is above the estimated value range
    • The valuation methods diverge

    Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA, FCF yield, Payout ratio (FCF).

    Versus the vertical median

    Listed companies from United Kingdom · same country · compared with 39 companies

    Multiples and returns vs the median

    P/E
    12.2x
    vertical median 15.1x
    below median (−19.0%)
    EV/EBITDA
    —
    vertical median —
    P/S
    10.2x
    vertical median 1.5x
    above median (+575.4%)
    P/B
    1.0x
    vertical median 2.1x
    below median (−51.1%)
    ROE
    8.7%
    vertical median 14.4%
    below median (−39.6%)
    Net margin
    83.4%
    vertical median 10.8%
    above median (+674.6%)
    EBIT margin
    —
    vertical median 22.9%
    Revenue YoY
    4.9%
    vertical median 7.9%
    below median (−38.4%)
    Net debt/EBITDA
    —
    vertical median —
    Dividend yield
    4.9%
    vertical median 2.9%
    above median (+67.5%)

    Price rebased to 100 (monthly, 5 years)

    Companies in the vertical

    Market capP/EROENet marginRevenue YoY1A / 3A
    BATS.LBritish American Tobacco P.L.C.101.0 bn13.116.5%30.3%−1.0%+3% / +82%
    ABF.LAssociated British Foods PLC14.4 bn14.19.2%5.3%−3.1%−7% / −16%
    0EV1.LCarnival PLC5.5 bn4.146.7%13.4%+6.4%unavailable / unavailable
    BAB.LBabcock International Group PLC5.0 bn24.434.7%4.1%+7.2%−11% / +155%
    AUTO.LAutotrader Group PLC4.8 bn16.360.2%47.1%+3.9%−13% / −23%
    BBY.LBalfour Beatty PLC4.3 bn16.423.2%2.8%+15.2%+21% / +162%
    ABDN.LAberdeen Group PLC4.0 bn10.68.0%28.9%−2.1%+8% / +37%
    BKG.LThe Berkeley Group Holdings PLC3.5 bn11.18.8%13.4%−4.2%−2% / −24%
    BME.LB&M European Value Retail PLC2.8 bn17.221.2%2.8%+3.7%+66% / −51%
    AJB.LAj Bell PLC2.4 bn22.649.9%33.1%+18.0%+7% / +126%
    ASHM.LAshmore Group PLC1.4 bn13.713.1%71.6%−0.1%+27% / +16%
    BCG.LBaltic Classifieds Group PLC1.2 bn23.215.8%57.6%+6.9%−99% / −99%
    APN.LApplied Nutrition PLC757.3 m35.941.2%19.7%+24.2%+70% / unavailable
    THRL.LTarget Healthcare REIT PLC744.3 m12.28.7%83.4%+4.9%+24% / +47%
    BAG.LA.G. Barr P.L.C.660.8 m14.214.4%10.8%+4.0%−9% / +24%
    ASC.LAsos PLC496.9 m—-81.3%-12.0%−14.7%+72% / +9%
    ALFA.LAlfa Financial Software Holdings PLC480.3 m16.061.5%23.8%+15.3%−29% / +8%
    AML.LAston Martin Lagonda Global Holdings PLC341.3 m—-93.4%-39.2%−20.6%−46% / −85%
    APTD.LAptitude Software Group PLC112.5 m28.77.2%6.2%−7.3%−30% / −23%
    AMGO.LAmigo Holdings PLC10.3 m———−81.9%+340% / +878%
    ASBE.LAssociated British Engineering PLC605.3 k—-19.1%—unavailableunavailable / unavailable
    AMIF.LAmicorp Fs (uk) PLC221.6 k0.127.5%9.1%+8.1%unavailable / unavailable
    AAF.LAirtel Africa PLC——24.1%10.6%+29.5%−11% / +154%
    AAL.LAnglo American PLC——-19.3%-20.2%+4.5%+30% / +76%
    ACG.LAcg Metals Limited——-80.3%-32.0%+134.8%+61% / +64%

    1- and 3-year price returns: for THRL.L from daily closes (the same as the performance table), for the other companies from month-end closes.

    olivLaw engine forecast

    The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

    The engine has no published run for this company yet.

    Valuation scenarios (editable assumptions)

    Illustrative scenarios

    Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

    Bear
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Base
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Bull
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Nothing is saved.

    Estimated price (GBP)

    Estimated priceBearBaseBull
    1 years
    0.71
    Total return -37% · Per year -37%
    1.26
    Total return 10% · Per year 10%
    1.90
    Total return 64% · Per year 64%
    3 years
    0.70
    Total return -31% · Per year -11%
    1.38
    Total return 31% · Per year 10%
    2.29
    Total return 111% · Per year 28%
    5 years
    0.68
    Total return -25% · Per year -5%
    1.52
    Total return 55% · Per year 9%
    2.76
    Total return 167% · Per year 22%
    What moves the 3-year price the most
    • Exit P/E± 0.35
    • Net margin± 0.24
    • Annual revenue growth± 0.20
    • Annual dilution± 0.02

    AI analysis

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    In brief

    Target Healthcare REIT plc owns a portfolio of UK care homes leased to operators on long-term contracts. In fiscal 2025 rent cover stayed above 1.9x 1 and occupancy stood at 86% 1, leaving room for growth, a relevant point given pressures in the social care sector.

    SWOT

    Strengths

    • A modern portfolio with a high share of homes built after 2010 and very long lease terms, which provides stable income 1.
    • Rent cover from operators at the highest level since listing, which lowers the risk of non-payment 1.
    • A large share of tenant revenue from private fees, which supports long-term growth 1.

    Weaknesses

    • The company's shares trade at a discount, which could limit access to new equity for growth 1.
    • Occupancy has not reached the long-term average, leaving potential growth unrealised 1.
    • Property transaction activity remained low in fiscal 2025 1.

    Opportunities

    • Growing investor interest in the sector could support property values and future transactions 1.
    • Raising occupancy towards the long-term average could improve home profitability 1.
    • Development of new homes with direct support could expand the portfolio 1.

    Threats

    • Staff shortages and higher wage costs could reduce operator profitability and their ability to pay rent 1.
    • Regulatory changes to rent reviews or social care could affect long-term income 1.
    • A negative perception of the sector could reduce demand and occupancy 1.

    Risks

    • Weak operator performancehigh

      If tenant operators cannot cover their costs, the company's income could fall, and the strategy of investing in new homes could add fill-up risk 1.

    • Inflation and rent review capsmedium

      If inflation were to exceed rent review caps, real income could decline, and higher operator costs could erode rent cover 1.

    • Interest rate riskmedium

      Interest rate changes could raise the cost of variable-rate debt, although most borrowings are fixed 1.

    • Negative sector perceptionmedium

      Negative events in the care sector could reduce demand for beds and damage the reputation of the portfolio 1.

    • Access to capitallow

      Without access to equity or debt, the company could be unable to grow through acquisitions 1.

    Investment thesis

    What would need to be true (bull case)

    • Rent cover at the highest level since listing and rising rents could support long-term income, if operators continue passing costs on to residents 1.
    • US investor interest in the sector could support property values and provide transaction evidence 1.
    • Scope to raise occupancy towards the long-term average could improve portfolio profitability 1.

    What would break the thesis

    • If operators fail to absorb staffing costs, rents could become harder to sustain 1.
    • Proposed rent review rules could have unintended effects on existing and future leases 1.
    • With shares trading at a discount, access to new capital for growth could remain limited 1.

    What to watch

    • Outcome of the first phase of the Baroness Casey social care review2026
    • Development of occupancy towards the long-term average in mature homesnext 10-K
    • Any final rules on upward-only rent review restrictions2026
    • Results of re-letting campaigns and the disposal of nine care homes after the year endnext 10-K

    Products, market & competition

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    The business

    The company invests in UK care homes that it leases to operators under triple net contracts with rents that rise each year. According to the annual report for the year ended 30 June 2025, the portfolio has diversified tenants, and a large part of tenant revenue comes from private fees 1. The strategy emphasises modern, high-quality buildings and a partnership between owner and operators.

    Asset management is performed by Target Fund Managers Limited, which monitors tenant performance, rent cover and re-letting of homes when needed. The report mentions re-letting homes to other operators on attractive financial terms 1.

    The company aims to reduce the carbon footprint of its portfolio, with a net zero target first for operations and then for the portfolio, as part of its ESG commitments 1.

    Segments

    Long-let care homes

    The main segment consists of care homes leased to operators on long terms with indexed rents and a high share of private fees, which supports income stability 1.

    Development and new investment

    A small number of development projects completed or progressed in fiscal 2025, while property transactions remained limited, with a significant disposal of care homes announced after the year end 1.

    Market context

    The UK care home investment market saw higher transaction volumes than the prior year, and US REITs have invested significantly in the sector 1. The report says market pricing has remained relatively flat in recent quarters 1. Private fee increases and partial local authority funding affect operator revenues 1.

    Valuation yields moved in line with the MSCI UK property index, and the company reported a total return above the benchmark for calendar 2024 1.

    Trends

    • Rising private feestailwind

      Operators have largely passed rising costs on to residents, with large annual private fee increases, which could support rents if families continue to pay 1.

    • Staffing cost pressureheadwind

      Minimum wage and national insurance increases raise operator costs, and restrictions on overseas recruitment could worsen staff shortages in the sector 1.

    • Social care reformmixed

      The social care review led by Baroness Casey could bring longer-term clarity, but its timing is uncertain and could be affected by elections 1.

    • Rent review regulationheadwind

      The government proposal to ban upward-only rent reviews could have unintended effects on properties outside retail, although details remain unclear 1.

    Competitive position

    Competition comes from other UK care home owners and from US REITs that have started investing in the sector and sometimes take ownership of operations as well 1. The company argues its partnership model and triple net leases are preferred by many operators 1.

    Differentiation rests on property quality, building age and the high share of en suite wet-rooms, indicators the company compares with national averages 1.

    • US-listed REITs active in UK care homes

      Investors that have recently entered the sector and in some cases also own the operations, not just the property 1.

    • Other UK care home property owners

      Private investors and funds competing for the same assets and operators in the sector 1.

    • Operators using management contract models

      Operators and investors that prefer management contract structures over long-term leases, seen as an alternative by some investors 1.

    • Social infrastructure investment funds

      New entrants that could increase demand for quality assets in the sector 1.

    News & filings

    In the press

    Annual reports (ESEF)

    Sources

    1. [1] Annual report, fiscal year ended 2025-06-30 (ESEF) · SEC / Target Healthcare REIT plc · 30 Jun 2025

    Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.

    Target Healthcare REIT plc (THRL.L): stock, results, valuation and forecast · olivLaw